A new study in the Aug. 15 issue of the Journal of Clinical Sleep Medicine suggests that continuous positive airway pressure (CPAP) therapy reduces the mortality rate in people who have both chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA).  Results show that even minimal use of CPAP was associated with some reduction in the risk of death, and this benefit increased with more nightly hours of CPAP therapy.